Last reviewed · How we verify
NCT07495371: HIP- STR
Passive Static Stretching for Improving Hip Range of Motion in Patients and Healthy Individuals
trial in Hip Joint Disorders in 12 participants. Completed in 3 December 2025.
28 November 2025
Quick facts
| Lead sponsor | Omicron beta research |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 12 |
| Start date | 3 November 2025 |
| Primary completion | 28 November 2025 |
| Estimated completion | 3 December 2025 |
| Sites | 1 location across Italy |
Conditions studied
- Hip Joint Disorders — all drugs for Hip Joint Disorders →
- Recovery After Total Hip Arthroplasty — all drugs for Recovery After Total Hip Arthroplasty →
- Healthy Individuals — all drugs for Healthy Individuals →
Sponsor
Omicron beta research
Who can join
Eligibility, any sex, with Hip Joint Disorders or Recovery After Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot study evaluates whether passive static stretching can improve hip movement in three groups: people who have had hip replacement surgery, individuals with long-term hip pain, and healthy volunteers. Participants will follow a 4-week stretching program, doing exercises three times per week under the supervision of a trained clinician. Hip range of motion will be measured before and after the program using accurate electronic sensors. The goal is to determine if passive static stretching is a safe and effective way to increase hip flexibility and support daily activities. The study involves no new medications or invasive procedures and is considered low risk.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07495371
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07495371 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Omicron beta research
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07495371.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing